chrisvoncsefalvay/vaers-outcomes huggingface dataset:
however was diagnosed with covid 19 infection yesterday; however was diagnosed with covid 19 infection yesterday; Also reported painful arm on injection site; headache; body ache; feeling very weak and has ' had a bad last couple of days" states she is doing better today but still weak.; This is a spontaneous report received from a Pfizer-sponsored Program COVAX US Support. A Contactable female Consumer (patient) reportedly received first dose of BNT162B2(BNT162B2, Solution for injection,start date/stop date: 01Feb) via unspecified route of administration on 01Feb (Batch/Lot Number: NA) as single dose for covid-19 immunization and she is scheduled for a second dose due on 22Feb. concomitant medications were not reported, she is diabetic and elderly. She was diagnosed with covid 19 infection yesterday.She reports that feeling very weak. The outcome of the events were not recovered, the outcome of the event painful arm on injection site with outcome unknown, headache with outcome unknown and body ache with outcome unknown for a few days after the first shot of the vaccine but went away after 3 days.she is asking if i need second shot of the vaccine since I tested covid positive.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained. No further information is expected.
Injection site, hot to touch; Swelling at the injection site; Blotchy red near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site, hot to touch), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Blotchy red near the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 immunisation.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site, hot to touch). 13-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Blotchy red near the injection site). The patient was treated with NAPROXEN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Injection site, hot to touch), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Blotchy red near the injection site) outcome was unknown.            Concomitant medications was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow-up information received  contains non-significant information
First 72hrs had expected red raised knot at injection site-painful. Day 7 post injection small circular red raised rash around injection site appeared. Rash continued to get bigger through day 10. On day 12 a second red raised rash on the under arm near armpit appeared. By day 14 post injection both rashes were gone.
Mother called office 6/04/07 reporting left upper leg to be swollen and red down to knee.
pt recv vax 17MAY96 & 21MAY96 pt exp paresthesia & tingling which began in lt arm & spread to other areas, including toes, shins & knees;also exp dizziness;pt exp joint aches revealed some hypesthesia of lt arm;
Came back  red and redder; Redness at injection site; Swelling at injection site; Hardness at injection site; Itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE INDURATION (Hardness at injection site), PRURITUS (Itching), ERYTHEMA (Came back  red and redder) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE INDURATION (Hardness at injection site), PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (Redness at injection site). On 30-Jan-2021, the patient experienced ERYTHEMA (Came back  red and redder). At the time of the report, VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE INDURATION (Hardness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) had resolved and PRURITUS (Itching) and ERYTHEMA (Came back  red and redder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.   Reporter did not allow further contact
This spontaneous report as received from a male consumer of unknown age refers to himself. The patient's medical history included appendix removed. The patient stated he received the ZOSTAVAX vaccine 2 to 3 years ago (estimated 2011 to 2012) (unspecified month and date) (dose, frequency, route, lot # unknown). The patient said he had several outbreaks of red blistery rash that scabbed over and disappeared. The patient currently had a chickenpox appearance pimple bump on his face that the physician was treating with a cream (brand, dose, and manufacturer unspecified) and the physician stated it was unrelated to the ZOSTAVAX vaccine he received. The patient sought medical attention via office contact. No diagnosis was given by the physician stated "the patient". The patient believed it was related. Patient present status was reported as not recovered. Patient provided little detail as he wanted to contact the physician for further consultation. Physician demographics were not provided. Additional information has been requested.
HEADACHES, DIZZINESS, JOINT PAIN, EXHAUSTION, RACING HEARTBEAT, HIVES ON FACE, CHEST AND ARMS. INJECTION SITE SWOLLEN, RED AND HOT TO TOUCH.
Intense "flu-like" symptoms from 12 to 48 hours including intense fatigue,  frontal and temporal headache, and very unusually intense generalized, multi-joint pain (ankles, knees, hips, back, fingers, thumbs, jaw, neck).  All of these symptoms subsided within 48 hours.    I had no chills and just an intermittent, very low grade temperature for 48 hours.    Additionally, I developed a generalized, "prickly" skin sensation  on full body, and an on-again, off-again, "buzzing" and tingling sensation on the bottom of both feet, just below the toes.  These subsided completely within 3 days.
moc states that p/vax pt devel a high pitched cry & fever (102 or >) & was inconsolable for > 3 hrs; treated w/APAP w/o relief;
Employee received a Tdap vaccine in the left deltoid muscle on 02/02/2009 at 1100.  The next day she had an approx 6"  red, swollen, warm to touch and painful area at the injection sight.  Also, had an approx 2cm eccymotic area at the sight.  This has persisted for the last four days.  There is some improvement noted today.
Information has been received from a physician concerning a 6-month-old male who was vaccinated PO with the first, second and third 2.0 ml doses, respectively, of Rotateq. The physician reported that on the night of 15-FEB-2007, the patient developed hematochezia and was taken to the emergency room. The patient subsequently recovered. Upon internal review, hematochezia was determined to be an other important medical event. Additional information has been requested.
Marked inflammation left thigh- detected by babysitter-area of injection edematous-marked redness and heat-2x3 area child afebrile-no restriction of movement-motrin given to reduce inflammation-by 03-07-03 reduced edema-redness fading.
Something stuck in my throat; Nausea; This is a spontaneous report from a contactable nurse (patient). A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1685; Expiration date was not reported) on 22Dec2020 (12:30) at a single dose on the left deltoid, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included allergy to lobster, and had used steroids. The patient's concomitant medications were not reported. On 24Dec2020, the patient had something stuck in the throat; and had nausea. The patient had an emergency room visit due to the reported events; and had received a three-day course of oral prednisone and antihistamine, and then diphenhydramine (BENADRYL). The patient had no respiratory, cardiovascular, dermatological or gastrointestinal manifestations. The outcome of the events, 'something stuck in the throat' and 'nausea', was recovered on an unspecified date. The reporter had considered that there was a reasonable possibility that the events were related to the suspect vaccine.
Pt reports a history of headaches which had always been relieved with aspirin. States that after receiving the 1st Anthrax shot she began to get consistent headaches unrelieved by aspirin.
Pt recv vax on unknown date; post vax pt exp dizziness & warm, flush feeling over body; sore arm, elevated BP, rapid pulse -94
felt faint; flu; weak; vomiting; nausea; fever; chills; muscle pain; joint pain; fatigue; site pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Apr-2021 at 10:45 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PYREXIA (fever), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue) and VACCINATION SITE PAIN (site pain at the injection site). On 06-Apr-2021, the patient experienced DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting) and NAUSEA (nausea). At the time of the report, DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting), NAUSEA (nausea), PYREXIA (fever), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue) and VACCINATION SITE PAIN (site pain at the injection site) outcome was unknown. Not Provided          It was reported that patient's was doing better for the unspecified event.   No concomitant product reported.  No treatment medication specified.   Action taken with mRNA-1273 in response to events was not applicable.
Fatigue; Nauseousness; Headache; Body ache; Pain in my right armpit; Chest pain; This is a spontaneous report from a contactable consumer (patient, nursing assistant) or other non-health care professional. A 22-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: FA6780; Expiration Date: 30Sep2021) via an unspecified route of administration on 24Jul2021, Saturday (at the age of 22-year-old) as dose 1, single for COVID-19 immunization. Medical history included HIV from an unknown date and unknown if ongoing. Concomitant medications included bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate (BIKTARVY) taken for HIV infection, start and stop date were not reported. Patient had no prior vaccination. On 24Jul2021, the patient experienced fatigue, nauseousness, headache, body ache, pain in right armpit, chest pain. It was reported that, this was all new, patient had no issues prior to the vaccine. Consumer stated for laboratory test consumer went every three months, not for two months. The patient underwent lab tests and procedures which included routine labs: unknown result on an unspecified date. No treatment received for the events. Outcome of the events were unknown.   Follow-up attempts are completed. No further information is expected.
Pt c/o R shoulder pain radiating up to neck and down to ribs. Started 2 days after Tdap administration. Injection site was high up on R deltoid. Some lymphadenopathy. Pain 7.5/10. No rashes, hives, swelling, induration, erythema, numbness/tingling. Symptoms unrelieved w/ NSAIDS. Pt also c/o frontal h/a x 3 days.
Systemic: Chills-Medium, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Medium, Additional Details: The patient felt dizzy about 3 minutes after receiving vaccine (after walking and sitting in observation area). Pharmacist ran out and caught patient as he lost consciousness and the patient was not injured. Patient regained consciousness after ~10 seconds. Pharmacist and Technician helped patient to lay on the floor and elevated feet. Vitals taken every 5 minutes. Lowest BP reading was 98/60. Patient offered water and drank some. Patient laid down for ~25 minutes, BP came up to 116/84.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, drug reactions or allergies, medical history and concomitant therapy was reported. On an unknown date in May 2017, the patient might have received one of the improperly stored lots of GARDASIL 9 (lot# M032650, expiration date 31-MAR-2019, dose and route of administration were not reported), PNEUMOVAX23 syringes (lot# M037533, expiration date 17-MAY-2017, dose and route of administration were not reported), M-M-R II (lot# M027637, expiration date 02-JUN-2018, therapy type, dose and route of administration were not reported) or ROTATEQ (lot# M038846, expiration date 26-APR-2018, orally, dose was not reported). The reporter was not sure which of the vaccines the patient received. The vaccines were stored in a temperature range from 9 to 25 degrees Celsius (20.04 degrees Celsius) for a total of 168 hours, from 01-MAY-2017 to 08-MAY-2017. There was no previous temperature excursion. Digital data logger was used. No adverse effect was reported. No product quality complaint was involved. Additional information has been requested.
Life destroyed/Feels like someone at night hits her with a baseball bat in the face; Now the pain is so bad/Achy/The pain is like the worst part of childbirth; Felt like she had the flu; Weak as water for 4 days; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Life destroyed/Feels like someone at night hits her with a baseball bat in the face), PAIN (Now the pain is so bad/Achy/The pain is like the worst part of childbirth), INFLUENZA (Felt like she had the flu) and ASTHENIA (Weak as water for 4 days) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 083J21A, 005C21A and 032B21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression, Trigeminal neuralgia (for 11 years with no symptoms and now the pain was so bad. It is called "The suicide disease"), Hypothyroidism, Cholesterol and Anxiety. Concomitant products included ALPRAZOLAM (XANAX) for Anxiety, PRAVASTATIN for Cholesterol, DULOXETINE HYDROCHLORIDE (CYMBALTA) for Depression, GABAPENTIN (NEUROTIN [GABAPENTIN]) for Trigeminal neuralgia.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2022, the patient experienced FEELING ABNORMAL (Life destroyed/Feels like someone at night hits her with a baseball bat in the face), PAIN (Now the pain is so bad/Achy/The pain is like the worst part of childbirth), INFLUENZA (Felt like she had the flu) and ASTHENIA (Weak as water for 4 days). The patient was treated with METHYLPREDNISOLONE at a dose of 4 milligram. On 02-Mar-2022, ASTHENIA (Weak as water for 4 days) had resolved. At the time of the report, FEELING ABNORMAL (Life destroyed/Feels like someone at night hits her with a baseball bat in the face), PAIN (Now the pain is so bad/Achy/The pain is like the worst part of childbirth) and INFLUENZA (Felt like she had the flu) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient received booster dose on 21-Feb-2022. Patient had no allergies and never tested positive for COVID-19 and She did not receive any other vaccine within one month prior to Moderna. Patient was using unknown medication of 0.50mg, once a day for Hypothyroidism. Patient had stated that said that she was furious because there was no warning on not taking the vaccine with her condition. Patient was not hospitalized.
lymph node swelling on the right side of my neck; Lung Adenocarcinoma with spread to the lymphs; This is a spontaneous report from a contactable consumer (patient). A 75-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 04Feb2021 (Lot Number: EL9265) at the age of 74-year-old as single dose for covid-19 immunisation. Medical history included chronic obstructive pulmonary disease. Concomitant medication included fluticasone propionate, salmeterol xinafoate (WIXELA INHUB) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2(lot number: EL3249) on 14Jan2021 at the age of 74-year-old at left arm for covid-19 immunisation. There was no other vaccine in four weeks. By end of February the patient noticed lymph node swelling on the right side of his neck. When he questioned it he was told that lymph swelling a common side effect and should subside in 4 to 6 weeks. In the interim rather than subsiding they increased in number of nodes and in size. When he reported it to his PCP, he look at them and assured him that it was not cancerous because they were mobile. They did not test or investigate as a precaution. On 06Aug2021, the patient was given a cancer diagnosis of lung adenocarcinoma with spread to the lymphs. It seemed the vaccine triggered something to get the cancer process rolling. He lost valuable time adhering to the guidance pertaining to the 4 to 6 week waiting period for the lymphs to go down. He believed that line should be discarded and replaced with more proactive wording to prevent future situations. Right now, his life was possibly on the line for waiting. And he really could use some assistance in this battle. Adverse events start date was 25Feb2021. Events resulted in: Doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event). Treatment received for the events. AE treatment reported as exam and diagnosis. The outcome of the events was not recovered. The patient had no COVID prior vaccination. No COVID tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. On unspecified dates, the patients were vaccinated with an unspecified number of improperly stored doses of ROTATEQ (lot # K024700, expiration date 30-JUL-2016, lot # L008051, expiration date 17-NOV-2016, lot # L008057, expiration date 01-DEC-2016, lot # L013192, expiration date 19-JAN-2017, route not provided). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Pain & swelling R deltoid.  Papular rash at R & L deltoid & upper back with itching.  Pt began having symptoms 06/21/08.
Received shot at 10:49 am did from office at 11 pm. Return to office screen child having problem breathing at 1140 am.
Pt recvd 2nd dose of Engerix-B & devel a rash more severe than prev rash;
Information has been received from a licensed practical nurse referring to multiple unspecified patients. The patient's medical history, concurrent conditions and concomitant medications were not reported. On multiple unspecified dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # L036301, expiration date 20-DEC-2017) via intramuscular injection for prophylaxis. No adverse effect was reported. No product quality complaint (PQC) was involved. The vaccine was stored in temperature between 46 degrees Fahrenheit and 77 degrees Fahrenheit for 5 hours and 50 minutes. "Data logger" was involved and there was no previous temperature excursion. This is one of several reports from the some source. Additional information has been requested.; Sender's Comments:  US-009507513-1703USA009130: US-009507513-1703USA009129:
Redness, pain, swelling (4 inches wide), nausea, dizziness, symptoms started the day after shot. Took ADVIL.
body aches; feeling brain fogginess; losing balance; arm started feeling numb; rashes; massive headache; This is a spontaneous report from a contactable consumer (patient) reported for self.  A patient of an unspecified age and gender received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), at an unknown route on 22May2021 as dose 2, single for COVID-19 immunization. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on an unknown date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was lean and healthy diet person. The patient experienced severe symptoms after a day such as massive headache, body aches and rashes, feeling brain fogginess, losing balance and my left arm started feeling numb on May2021, reported that "which they were never happy to me before". The patient believed these symptoms suddenly happened to me after took the shots are related to the effect of the shots. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow-up (17Sep2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
pt reportedly in usual good hlth; pt recvd vax & about 45 mins later because sleepy, unarousable, pale; referred to hosp; exam nl;